Seaport Therapeutics Appoints Robert J. Hombach to Board of Directors
Key Highlights Robert J. Hombach joins Seaport Therapeutics’ Board of Directors and will chair the Audit Committee. Brings three decades of financial and operational…
Browsing Tag
Daphne Zohar
4 posts
Seaport Therapeutics Appoints Dr. David Wheadon to Board of Directors
Key Highlights Seaport Therapeutics appoints Dr. David Wheadon to its Board of Directors. Dr. Wheadon has over three decades…
Seaport Therapeutics Expands Executive Team with Key Appointments
Key Highlights Antony Loebel, M.D., appointed as Chief Medical Officer and President of Clinical Development. Lana Gladstein, J.D.,…
PureTech Health Advances Strategic Initiatives, Launches Seaport Therapeutics
Key Highlights Seaport Therapeutics launches with $100M in Series A financing to develop neuropsychiatric medicines. Leadership Transition: Daphne Zohar steps…